Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 3

Catheter-based renal sympathetic denervation induces acute renal inflammation through activation of caspase-1 and NLRP3 inflammasome

Pages
134–141
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Apoptosis-associated speck-like protein containing a caspase recruitmentdomain and NLRP3 expressions increased immediately and then decreased at week 2 after RDN.Conclusion: The RDN could induce acute renal inflammation through the activation of caspase-1 and NLRP3 inflammasome. (Anatol J Cardiol2019; 21: 134-41)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Catheter-based renal sympathetic denervation (RDN) is implemented as a strategy to treat resistant hypertension.
📊
Key Findings & Data:Serum creatinineand estimated glomerular filtration rate have some limitations to predict the early stage of acute kidney injury (AKI).
💡
Conclusion & Impact:Apoptosis-associated speck-like protein containing a caspase recruitmentdomain and NLRP3 expressions increased immediately and then decreased at week 2 after RDN.Conclusion: The RDN could induce acute renal inflammation through the activation of caspase-1 and NLRP3 inflammasome. (Anatol J Cardiol2019; 21: 134-41)
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Catheter-based renal sympathetic denervation (RDN) is implemented as a strategy to treat resistant hypertension. Serum creatinineand estimated glomerular filtration rate have some limitations to predict the early stage of acute kidney injury (AKI). We investigated the changesof early inflammatory biomarkers in AKI following the RDN procedure.Methods: Twenty-five female swine were divided into three groups: normal control (Normal, n=5), sham-operated (Sham, n=5), and RDN groups(RDN, n=15). The RDN group was further subdivided into three subgroups according to the time of sacrifice: immediately (RDN-0, n=5), 1 week(RDN-1, n=5), and 2 weeks (RDN-2, n=5) after RDN. Renal cortical tissue was harvested, and clinical parameters and inflammatory biomarkerswere checked.Results: There were no significant changes in the clinical parameters between the normal control and sham-operated groups using contrastmedia. Inflammatory interleukin (IL)-1β, IL-18, IL-6, tumor necrosis factor-α, and anti-inflammatory IL-10 increased immediately and then decreased at week 2 after RDN in the renal cortical tissue. Leaderless protein, IL-1α level, increased at week 1 and then decreased at week 2after RDN. Caspase-1 increased immediately after RDN until week 2. Apoptosis-associated speck-like protein containing a caspase recruitmentdomain and NLRP3 expressions increased immediately and then decreased at week 2 after RDN.Conclusion: The RDN could induce acute renal inflammation through the activation of caspase-1 and NLRP3 inflammasome. (Anatol J Cardiol2019; 21: 134-41)

🔖

Cite This Article

LEE, D. W., KIM, J. S., KİM, I. Y., KIM, H. S., KIM, J. Y., RHEE, H., SEONG, E. Y., SONG, S. H., LEE, S. B., EDELSTEIN, C., KWAK, I. S. (2019). Catheter-based renal sympathetic denervation induces acute renal inflammation through activation of caspase-1 and NLRP3 inflammasome. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 3, 134–141. https://ajindex.com/articles/365745

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al.
  2. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  3. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003
  4. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014
  5. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008
  6. Sarafidis PA, Bakris GL. Resistant hypertension. An overview of evaluation and treatment. J Am Coll Cardiol 2008
  7. Krum H, Schlaich M, Whitbourn R, Sobotka P, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: multicentre safety and proof-of-principle cohort study. Lancet 2009
  8. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010
  9. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 2011
  10. Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol 2014
  11. Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, et al.
  12. SYMPLICITY HTN-3 Investigators. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol 2015
  13. Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, et al.
  14. Renal Denervation for Hypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denerv